NetraMark Holdings Inc.
Loading stock data...
Stock Performance
Price History
-
Drag to select time range
-
Market Data
Market Cap
90.0M
P/E Ratio
-
52-Week High
-
52-Week Low
-
Avg Volume
-
Beta
-
Forward P/E
-
Dividend Yield
-
EV/Revenue
-
Price/Book
-
Business Overview
NetraMark Holdings Inc. provides AI-powered insights and software solutions to trial sponsors, clinical research organizations, and biotechnology companies worldwide. It operates NetraAI platform, an advanced machine learning system purpose-built for analyzing complex clinical trial data to identify meaningful patient subpopulations. The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023. NetraMark Holdings Inc. was founded in 2016 and is headquartered in Toronto, Canada.
Healthcare
Health Information Services
TSX
Key Financial Metrics
432,495
Revenue
-5.2M
Net Income
C$-0.07
EPS (Diluted)
-3.8M
Free Cash Flow
Profitability
Gross Margin
-
Operating Margin
-1207.3%
Net Profit Margin
-1207.3%
EBITDA
-5.2M
Returns & Efficiency
Return on Assets (ROA)
-239.9%
Return on Equity (ROE)
-284.6%
Dividend Yield
-
Payout Ratio
-
Financial Health
Total Assets
2.2M
Total Debt
-
Debt to Equity
-
Current Ratio
6.36
Company Info
| Industry | Health Information Services |
| HQ | Toronto, Canada |
| Fiscal Year End | 1759190400 |
| Currency | CAD |
| Website | www.netramark.com |
Peers
Bausch + Lomb Corporation
BLCO.TO
7.9B
P/E: --
Bausch Health Companies Inc.
BHC.TO
2.5B
P/E: 12.0
Extendicare Inc.
EXE.TO
2.5B
P/E: 23.7
Sienna Senior Living Inc.
SIA.TO
2.2B
P/E: 53.2
Cronos Group Inc.
CRON.TO
1.4B
P/E: 24.1
Tilray Brands, Inc.
TLRY.TO
1.2B
P/E: --
WELL Health Technologies Corp.
WELL.TO
1.1B
P/E: --
Knight Therapeutics Inc.
GUD.TO
631.8M
P/E: --
Insider Activity
Sentiment
Bullish
Shares Bought
3,588,546
Shares Sold
0
Total Transactions
49
SEDAR+ Filings
View All Filings2
Annual Reports
9
Quarterly Reports
10
MD&A
92
News Releases
13
Material Changes
3
Governance
24
Certifications
26
Other
●
2026-01-19
●
2026-01-14
●
2025-05-09
●
2025-05-09
●
2025-05-09
Interactive Charts
Company Profile
General Information
| Company Name | NetraMark Holdings Inc. |
| Ticker | AIAI.TO |
| Exchange | TSX |
| Sector | Healthcare |
| Industry | Health Information Services |
| Headquarters | Toronto, Canada |
| Fiscal Year End | 1759190400 |
| Currency | CAD |
| Website | www.netramark.com |
Financial Summary
| Market Cap | 90.0M |
| Revenue | 432,495 |
| Net Income | -5.2M |
| P/E Ratio | N/A |
| EPS (Diluted) | C$-0.07 |
| Net Margin | -1207.3% |
| ROE | -284.6% |
| Dividend Yield | N/A |
Business Description
NetraMark Holdings Inc. provides AI-powered insights and software solutions to trial sponsors, clinical research organizations, and biotechnology companies worldwide. It operates NetraAI platform, an advanced machine learning system purpose-built for analyzing complex clinical trial data to identify meaningful patient subpopulations. The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023. NetraMark Holdings Inc. was founded in 2016 and is headquartered in Toronto, Canada.